1Tu DG, Wang ST, Chang TT, et al.The value of .serum tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma.Cancer, 1999,20( 1 ):147-152.
2Schneider J,Philipp M, Velcovsky HG,et al. Pro-gastrin-releasing peptide (P20GRP), neuron specific enolase ( NSE ), carcinoembryonic antigen(CEA) and cytokeratin 19-fragments (CYFAA21-1) in patients with lung cancer in comparison with other lung diseases. Anticancer Res, 2003,23 (2A):885-893.
3Aderka D,Engelmam H,Homik V, et al. Increased ,serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res, 1991,51 (10) :5602-5608.
2[3]Kwa HB,Verheijen MG.Prognostic factor in resected nonsmall cell lung cancer:an immunohistochemical study of 39 case[J].Lung cancer:1996.16(1):35~45.
3[5]Morris GF,Mathews MB,Regulation of proliferating cell nuclear antigen during the cell cycle.J Biol chem,1989,264:1385~1386.
4[6]Ramachandres.Immunochistochemical distrbution of C-erbB-2 in situ breast carcinoma~A detialed morphological analysis.J Pathol,1990May:161 (1):7~14.
5[7]Nowel PC,Mechanism of tumar Progress ion[J].Cancer Res.1986.46:2203~2207.
6[9]Wang YX,Yang ZY,Ding Y,et al.Correlation between CT and DNA contents in peripheral lung cancer[J].Euro J Radio,1991,13:43~5.